ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/09/2019
Back to search
Official data from USPTO
AMPLIGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
10/09/2019
Trademark type
Word
Nice classes
5
Filing date
09/02/1986
Registration date
12/06/1988
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/21/2018
Last transaction
12/21/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
08/17/1983
First use in commerce
08/17/1983
Drawing code
1
Owner type
03
Owner location
OCALA, FL, US
Law office
570
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
AIM IMMUNOTECH INC.
HEMISPHERX BIOPHARMA, INC.
HEM PHARMACEUTICALS CORP.
H. I. (pessoa física)
Representatives
DONNA J. BUNTON NIXON & VANDERHYE P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
INTRAVENOUS SOLUTION FOR USE IN THE TREATMENT OF VIRAL INFECTIONS
Publications
History of USPTO decisions and trademark events.
25 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/21/2018
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
12/21/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/21/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/18/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
12/05/2018
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/06/2009
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/06/2009
PLGL
ASSIGNED TO PARALEGAL
03/04/2009
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
02/20/2009
PAPER RECEIVED
02/20/2009
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/17/2008
CFIT
CASE FILE IN TICRS
08/06/2008
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/01/1995
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
12/05/1994
R.PR
REGISTERED-PRINCIPAL REGISTER
12/06/1988
PUBO
PUBLISHED FOR OPPOSITION
09/13/1988
NPUB
NOTICE OF PUBLICATION
08/12/1988
CRTP
REG. CANCELLED - RESTORED TO PENDENCY
06/02/1988
AMD7
SEC 7 REQUEST FILED
01/27/1988
R.PR
REGISTERED-PRINCIPAL REGISTER
07/28/1987
PUBO
PUBLISHED FOR OPPOSITION
05/05/1987
NPUB
NOTICE OF PUBLICATION
04/03/1987
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/13/1987
CNRT
NON-FINAL ACTION MAILED
01/08/1987
Continuous trademark protection
Get notified about every new filing that threatens AMPLIGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.